Allergan CEO Pushes for Trump to Lead Drug Price Discussions
When asked about President Trump’s calls to deal with high US drug costs, Allergan Chief Executive Officer Brent Saunders told Bloomberg News that President Trump should lead negotiations with drugmakers to restrain prices. The administration also could waive federal antitrust rules that currently prohibit drugmakers from discussing pricing so they could put together guidelines to follow, Mr. Saunders said.
To read the full story, visit www.bloomberg.com/news/articles/2017-02-23/allergan-ceo-pushes-for-trump-to-lead-drug-price-restraint-talks
You must be logged in to leave a comment.